As of 2:30 PM on the 11th, Nokchipja Cell is trading at 52,900 KRW, down 0.19% from the previous day. This represents a 30.46% increase compared to July 16. Nokchipja Cell is known as a developer and manufacturer of anticancer immune cell therapies.
Today, foreigners are tentatively recorded as net sellers of 16,000 shares. Over the past five days, individual investors have net sold 77,823 shares, while foreigners and institutions have net bought 78,606 shares and 5,727 shares, respectively.
On August 10, Nokchipja Cell became a market issue with the headline "Institutions net buying for 6 consecutive trading days... up 8.83%."
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
